Clinical Trials Directory

Trials / Completed

CompletedNCT02481778

Monitoring Radiation Induced Cardiac Damage by Blood Markers

Status
Completed
Phase
Study type
Observational
Enrollment
96 (actual)
Sponsor
University Medical Center Groningen · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Rationale: Radiation induced cardiac toxicity after treatment for intrathoracic tumours is a clinically relevant problem. So far, no clinical prediction models exist for cardiac toxicity. In particular, the relationship between radiation dose parameters and the risk of cardiac toxicity remains to be determined. Clinical prediction models for cardiac toxicity are difficult to obtain, e.g. due to long latency time. Therefore, objective surrogate markers, for cardiac toxicity such as NT pro BNP and hs-TNT, as obtained during and after treatment may be of great value. Objective: The main objective to find a correlation between the rise in NT pro BNP level and the radiation dose given to the heart.

Conditions

Interventions

TypeNameDescription
OTHERBlood sampling

Timeline

Start date
2015-09-08
Primary completion
2020-08-01
Completion
2020-08-01
First posted
2015-06-25
Last updated
2024-02-28

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT02481778. Inclusion in this directory is not an endorsement.